A systematic review...
 
Notifications
Clear all

A systematic review and meta-analysis on overall survival, failure-free survival and safety outcomes in patients with metastatic hormone-sensitive prostate cancer treated with new anti-androgens

1 Posts
1 Users
0 Likes
559 Views
(@j)
Joined: 6 years ago
Posts: 2160
Topic starter  

https://journals.lww.com/anti-cancerdrugs/Abstract/9900/A_systematic_review_and_meta_analysis_on_overall.97.aspx

"The addition of either abiraterone, apalutamide, darolutamide or enzalutamide to ADT improves OS and failure-free survival in hormone-sensitive metastatic prostate cancer, albeit an increase in AEs."


   
Quote
Share: